ABCA4 rs1800558: What Your Genotype Means
The rs1800558 variant is a well-studied missense change in the ABCA4 gene that substitutes the amino acid glycine with glutamic acid at position 1961 (p.Gly1961Glu). Often characterized as a mild or hypomorphic allele, it is statistically associated with late-onset Stargardt disease and complex macular phenotypes when paired with another pathogenic ABCA4 change. Understanding this variant provides insight into the nuanced genetics of inherited retinal conditions.
What each genotype means
Typical risk profile
You carry two reference copies of the ABCA4 gene at this position without the Gly1961Glu missense alteration. This genotype is not associated with an elevated risk of late-onset ABCA4-related macular dystrophy or Stargardt disease. However, standard age-related visual health guidelines and general family history considerations still apply.
Carried by approximately 98% to 99% of individuals across most non-African populations, including Europeans.
Carrier of hypomorphic allele
You carry one copy of the Gly1961Glu (G1961E) hypomorphic allele in the ABCA4 gene. Stargardt disease is inherited in an autosomal recessive manner, meaning a single copy typically does not cause disease unless paired with another pathogenic ABCA4 variant on the other chromosome. In rare cases, carriers have shown mild localized macular alterations or an increased statistical association with complex late-onset macular changes.
Found in about 1% of individuals of European ancestry, but reaches carrier frequencies of up to 8% to 10% in populations from the Horn of Africa.
Elevated macular dystrophy risk
You carry two copies of the Gly1961Glu hypomorphic missense variant in ABCA4. Having two copies of this variant is classically linked to late-onset Stargardt disease often presenting as localized 'bull's eye' maculopathy, although clinical severity and penetrance can vary. Because ABCA4 retinopathies involve retinal vitamin A metabolism, individuals are advised to discuss any high-dose vitamin A supplementation with their ophthalmologist.
Extremely rare globally, occurring in fewer than 1 in 10,000 individuals in most populations, but somewhat higher in select East African communities.
Understanding rs1800558 and the ABCA4 Gene
The single nucleotide polymorphism rs1800558 sits within the ABCA4 gene, located on chromosome 1. At the nucleotide level, this alteration reflects a transition from guanine to adenine at position 5882 of the coding sequence (c.5882G>A), resulting in a glycine-to-glutamic-acid substitution (p.Gly1961Glu) in the encoded protein. The ABCA4 gene encodes the ATP-binding cassette transporter member A4, an essential flippase localized primarily to the disc membranes of retinal photoreceptor outer segments. In healthy eyes, the ABCA4 transporter plays a critical role in the visual phototransduction cycle by clearing toxic all-trans-retinal derivatives from the photoreceptor discs. When the ABCA4 protein function is impaired, toxic bisretinoid compounds such as lipofuscin accumulate in the retinal pigment epithelium, predisposing photoreceptor cells to degeneration over time.
Clinical Significance and Disease Associations
In clinical genetics, rs1800558 is traditionally classified as a mild or hypomorphic pathogenic variant rather than a classic severe, loss-of-function mutation. In classical Mendelian genetics, autosomal recessive Stargardt disease (STGD1) requires two disease-causing variants in trans (one inherited from each parent). When an individual carries rs1800558 alongside a severe loss-of-function ABCA4 variant, the resulting condition is typically a milder, later-onset form of macular dystrophy, characterized by focal foveal atrophy and preserved peripheral vision. The evidence supporting this association is solid in familial and cohort studies, although overall evidence is categorized as limited or complex regarding solitary risk. Alone or in an asymptomatic heterozygous state, carrying one copy of the A allele does not cause disease, but researchers are continuing to evaluate its possible contributions to complex age-related macular changes.
The Incomplete Penetrance and Homozygote Mystery
A key biological intrigue surrounding rs1800558 is its phenotypic variability and apparent incomplete penetrance. Geneticists have observed that homozygous individuals (carrying two copies of the A allele) frequently present with very mild disease later in adulthood, or sometimes show no detectable macular symptoms at all. This has sparked intense research into genetic modifiers. Recent studies indicate that additional non-coding variants, such as deep-intronic variants acting in cis on the same chromosome, can alter how strongly the variant affects the retina. Additionally, environmental factors like cumulative light exposure and lipid metabolism may influence clinical outcomes. Because phenotype severity depends heavily on what variant is present on the opposite chromosome, rs1800558 serves as a textbook example of genetic nuance where genotype alone does not dictate absolute clinical fate.
Actionable Steps and Practical Limitations
Direct-to-consumer genetic profiles that report rs1800558 often cause unnecessary alarm if misunderstood. It is vital to recognize that possessing a single A allele merely denotes carrier status for a recessive trait; it does not constitute a diagnosis of Stargardt disease or visual impairment. Individuals cannot use raw genotyping data to determine phasing (whether two detected variants sit on the same or opposite chromosomes), nor can standard commercial tests capture the complex deep-intronic mutations known to modify ABCA4. If you have a family history of inherited retinal dystrophy or experience visual symptoms like central vision loss, you should consult an ophthalmologist or a board-certified genetic counselor. Clinical-grade diagnostic sequencing and comprehensive retinal examinations (such as fundus autofluorescence and electroretinography) are required to establish meaningful clinical guidance.
How common is this variant?
The minor allele (A) frequency is approximately 0.005 (0.5%) in broad European populations, rising to roughly 2.3% in Ashkenazi Jewish populations and exceeding 10% in specific regional cohorts such as the Horn of Africa.
Frequently asked questions
What is the difference between Stargardt disease and age-related macular degeneration?
Stargardt disease is a rare, typically monogenic inherited retinal condition primarily caused by biallelic mutations in the ABCA4 gene. Age-related macular degeneration (AMD) is a complex multifactorial condition driven by many genetic markers, advanced age, and lifestyle factors. Mild, late-onset ABCA4 variants like rs1800558 can sometimes mimic AMD features clinically.
Does carrying the rs1800558 variant mean I will go blind?
No. Carrying a single copy of rs1800558 makes you a healthy carrier, which does not cause vision loss on its own. Even in biallelic disease cases, the p.Gly1961Glu variant is classically associated with slower disease progression and preserved peripheral vision compared to severe mutations.
Can commercial ancestry tests confirm if I have ABCA4 retinal dystrophy?
No, commercial ancestry tests are not diagnostic tools. They typically only assess single points in the genome and cannot determine whether multiple variants are located on the same or opposite parental chromosomes, nor do they sequence deep-intronic modifier regions necessary for diagnosis.
Should I change my diet or take supplements if I have this variant?
You should not start high-dose supplements, particularly vitamin A, without clinical guidance, as excess vitamin A can accelerate toxic byproduct buildup in ABCA4-deficient pathways. Discuss any supplements or lifestyle changes with an eye care specialist or genetic counselor.
Sources & further reading
Educational information only, last refreshed 9/14/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1800558?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in ABCA4
A variant in the ABCA4 gene associated with Stargardt disease.
Pathogenic missense variant in ABCA4 causing autosomal recessive Stargardt disease and cone-rod dystrophy.
Genomic variant within the ATP-binding cassette retinal transporter ABCA4 locus implicated in retinal degenerations and macular disease.
Known as the Gly1961Glu (G1961E) variant in ABCA4, a prevalent hypomorphic mutation contributing to late-onset Stargardt disease and cone-rod dystrophy.
A well-documented pathogenic missense change in ABCA4 causing autosomal recessive Stargardt disease and cone-rod dystrophy.
Pathogenic missense variant in ABCA4 (p.Leu541Pro) causing Stargardt disease and juvenile macular dystrophy.